Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Transdermal buspirone pivotal trials

Feb. 21, 1997

Sanofi Winthrop reveals calpain inhibitors

Feb. 21, 1997

Novel kappa-opioid agonist from Parke-Davis

Feb. 20, 1997

Athena Neurosciences and Lilly extend research collaboration

Feb. 20, 1997

SIBIA Neurosciences initiates clinical trials of antiparkinsonian product

Feb. 20, 1997

Cortex seeks AMPAkine patent approval

Feb. 20, 1997

Vasogen to extend clinical trials with VasoCare

Feb. 20, 1997

Subtype-selective 5-HT1 antagonists from Pierre Fabre

Feb. 20, 1997

Astra anesthetic/analgesic introduced in the U.K.

Feb. 19, 1997

GRC-active agents from CoCensys modulate brain excitability

Feb. 19, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...